• Return to Headlines

Relatively Low EBITDA Growth Detected in Shares of Anika Therapeuti in the Health Care Supplies Industry (ANIK, RTIX, NEOG, WST, HYH)

By Nick Russo

Below are the three companies in the Health Care Supplies industry with the lowest EBITDA Growth (next year estimate vs. LTM). EBITDA Growth can be valuable in predicting future cash flow generation and earnings power.

Anika Therapeuti ranks lowest with a EBITDA growth of -21.2%. Rti Surgical Inc is next with a EBITDA growth of -0.7%. Neogen Corp ranks third lowest with a EBITDA growth of 18.3%.

West Pharmaceut follows with a EBITDA growth of 33.4%, and Halyard Health rounds out the bottom five with a EBITDA growth of 36.7%.

SmarTrend recommended that subscribers consider buying shares of Halyard Health on May 2nd, 2018 as our technology indicated a new Uptrend was in progress when shares hit $51.22. Since that recommendation, shares of Halyard Health have risen 11.8%. We continue to monitor Halyard Health for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: lowest ebitda growth anika therapeuti rti surgical inc neogen corp west pharmaceut halyard health

Ticker(s): ANIK RTIX NEOG WST HYH